Synergistic pharmaceutical compositions containing triamcinolone acetonide and halcinonide
CA 2216700 C · Owner: Massa Technology S.A. · Inventors: Chriki, Georges
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A pharmaceutical composition comprises a synergistic combination of at least about 0.01 % by wt. triamcinolone acetonide and at least about 0.01 % by wt. halcinonide as active ingredients therein in , combination with a pharmaceutically acceptable carrier for treating psoriasis or eczema, dermatitis. rosacea and/or other similar dermatological conditions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 27, 1995 and granted September 17, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 27, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 27, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.